Stock listing
BOATS:CGEM Cullinan Therapeutics, Inc. Stock
US listing (BOATS) of Cullinan Therapeutics, Inc. · home listing NASDAQ:CGEM
Follow Cullinan Therapeutics, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:CGEM
$14.93 USD -0.10 (-0.7%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:CGEM
- Day range
- $14.63 – $15.35 USDNov 2, 2026
- Volume
- 730,709 sharesNov 2, 2026
- Market cap
- $917.6M USDAt the close on Nov 2, 2026 · price × 61.46M shares outstanding
- 52-week range
- $6.73 – $23.19 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $16.18M USDMedian day 756,700 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CGEM · Home | $14.93 USD | -0.10 (-0.7%) | 730,709 | $15.13 | $15.35 | $14.63 | $15.03 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:CGEM · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $14.93 | -0.10 | -0.7% | $15.13 | $15.35 | $14.63 | 730,709 | |
| $15.03 | -0.42 | -2.7% | $15.38 | $15.72 | $14.70 | 389,409 | |
| $15.45 | -0.11 | -0.7% | $15.60 | $16.19 | $15.35 | 459,088 | |
| $15.56 | +0.72 | +4.9% | $14.93 | $15.62 | $14.74 | 594,218 | |
| $14.84 | +0.30 | +2.1% | $14.66 | $14.91 | $14.28 | 488,038 | |
| $14.54 | +0.17 | +1.2% | $14.71 | $14.87 | $14.39 | 438,389 | |
| $14.37 | -0.55 | -3.7% | $14.95 | $14.95 | $13.86 | 485,204 | |
| $14.92 | +0.03 | +0.2% | $14.82 | $15.32 | $14.64 | 392,651 | |
| $14.89 | +0.06 | +0.4% | $14.92 | $15.26 | $14.64 | 690,976 | |
| $14.83 | +0.85 | +6.1% | $13.92 | $14.92 | $13.85 | 694,016 | |
| $13.98 | +1.05 | +8.1% | $13.02 | $14.00 | $12.77 | 862,461 | |
| $12.93 | -1.07 | -7.6% | $13.91 | $13.91 | $12.81 | 1,123,300 | |
| $14.00 | +0.36 | +2.6% | $13.62 | $14.18 | $13.46 | 972,100 | |
| $13.64 | -0.46 | -3.3% | $13.81 | $14.18 | $13.44 | 903,500 | |
| $14.10 | -0.85 | -5.7% | $14.86 | $14.93 | $14.08 | 590,300 | |
| $14.95 | -0.58 | -3.7% | $15.45 | $15.64 | $14.88 | 372,400 | |
| $15.53 | +0.07 | +0.5% | $15.41 | $15.95 | $15.24 | 567,500 | |
| $15.46 | -0.17 | -1.1% | $15.60 | $15.71 | $14.81 | 1,137,400 | |
| $15.63 | -0.62 | -3.8% | $15.95 | $16.46 | $15.47 | 808,200 | |
| $16.25 | +0.21 | +1.3% | $17.24 | $17.70 | $16.06 | 2,017,000 | |
| $16.04 | +0.53 | +3.4% | $15.59 | $16.55 | $15.13 | 1,083,000 | |
| $15.51 | +0.98 | +6.7% | $14.76 | $15.56 | $14.59 | 1,162,100 | |
| $14.53 | -0.82 | -5.3% | $15.22 | $15.39 | $14.49 | 910,800 | |
| $15.35 | +0.12 | +0.8% | $15.39 | $15.78 | $14.96 | 1,067,200 | |
| $15.23 | +0.28 | +1.9% | $15.00 | $15.44 | $14.68 | 1,244,400 | |
| $14.95 | +0.14 | +0.9% | $14.71 | $15.19 | $14.20 | 1,109,200 | |
| $14.81 | -0.63 | -4.1% | $15.62 | $15.62 | $14.67 | 1,715,500 | |
| $15.44 | -1.43 | -8.5% | $16.60 | $16.88 | $14.80 | 2,728,800 | |
| $16.87 | -4.80 | -22.2% | $21.67 | $21.67 | $16.78 | 2,593,300 | |
| $21.67 | +0.32 | +1.5% | $21.44 | $21.88 | $21.27 | 831,800 | |
| $21.35 | +0.27 | +1.3% | $21.45 | $21.79 | $20.98 | 763,900 | |
| $21.08 | -0.28 | -1.3% | $21.38 | $21.45 | $20.63 | 3,251,000 | |
| $21.36 | +0.73 | +3.5% | $21.06 | $21.58 | $20.81 | 756,700 | |
| $20.63 | +0.09 | +0.4% | $20.50 | $20.84 | $20.20 | 825,700 | |
| $20.54 | +0.14 | +0.7% | $20.38 | $20.71 | $19.64 | 1,060,500 | |
| $20.40 | -0.19 | -0.9% | $18.55 | $20.93 | $18.51 | 1,418,200 | |
| $20.59 | -0.41 | -2.0% | $21.16 | $21.34 | $20.10 | 1,090,400 | |
| $21.00 | -0.31 | -1.5% | $20.99 | $21.22 | $20.50 | 805,600 | |
| $21.31 | -0.38 | -1.8% | $21.30 | $21.80 | $21.08 | 1,278,700 | |
| $21.69 | -0.40 | -1.8% | $21.61 | $22.41 | $21.28 | 953,700 | |
| $22.09 | -0.07 | -0.3% | $21.88 | $22.30 | $21.77 | 562,200 | |
| $22.16 | -0.17 | -0.8% | $22.39 | $22.68 | $21.65 | 524,100 | |
| $22.33 | +0.54 | +2.5% | $21.88 | $22.79 | $21.75 | 769,700 | |
| $21.79 | -0.28 | -1.3% | $21.80 | $22.07 | $21.55 | 546,100 | |
| $22.07 | +0.37 | +1.7% | $21.50 | $22.23 | $21.34 | 682,500 | |
| $21.70 | -0.90 | -4.0% | $22.60 | $22.88 | $21.57 | 630,100 | |
| $22.60 | -0.25 | -1.1% | $22.55 | $22.96 | $22.19 | 471,900 | |
| $22.85 | -0.10 | -0.4% | $22.66 | $23.19 | $22.42 | 683,300 | |
| $22.95 | +1.13 | +5.2% | $22.16 | $23.06 | $22.16 | 519,255 | |
| $21.82 | +0.14 | +0.6% | $21.62 | $22.37 | $21.16 | 617,367 | |
| $21.68 | +0.30 | +1.4% | $21.72 | $22.11 | $21.40 | 758,100 | |
| $21.38 | -1.14 | -5.1% | $22.14 | $22.25 | $21.02 | 902,500 | |
| $22.52 | +1.68 | +8.1% | $21.48 | $22.54 | $21.22 | 706,800 | |
| $20.84 | +0.25 | +1.2% | $20.23 | $21.20 | $19.99 | 595,100 | |
| $20.59 | +0.25 | +1.2% | $20.02 | $21.22 | $19.90 | 894,700 | |
| $20.34 | +0.70 | +3.6% | $19.31 | $20.37 | $18.58 | 565,800 | |
| $19.64 | +0.04 | +0.2% | $20.72 | $21.00 | $18.78 | 1,802,300 | |
| $19.60 | -0.03 | -0.2% | $19.61 | $19.94 | $19.39 | 676,000 | |
| $19.63 | +1.35 | +7.4% | $18.76 | $19.82 | $18.24 | 808,168 | |
| $18.28 | +0.55 | +3.1% | $17.44 | $18.33 | $17.30 | 663,852 | |
| $17.73 | -0.22 | -1.2% | $18.14 | $18.43 | $17.39 | 361,700 | |
| $17.95 | +0.34 | +1.9% | $17.67 | $17.99 | $17.06 | 595,400 | |
| $17.61 | +0.06 | +0.3% | $17.65 | $17.95 | $17.19 | 465,500 | |
| $17.55 | +1.30 | +8.0% | $16.38 | $17.88 | $16.38 | 664,300 | |
| $16.25 | -0.25 | -1.5% | $16.50 | $16.71 | $16.02 | 386,700 |
- Ticker
- BOATS:CGEM
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Oct 27, 2026
Cullinan Therapeutics Advances Velinotamig into Global Clinical Development for Autoimmune Cytopenias Following IND Clearance by the U.S. FDA
Latest deck · October 2026
Investor Presentation (October 2026)
Investor deck · 64 slides
Latest news
Cullinan Therapeutics Advances Velinotamig into Global Clinical Development for Autoimmune Cytopenias Following IND Clearance by the U.S. FDA
Oct 27, 2026
Closed $14.84 (+2.1%) on Oct 27, 2026
Zipalertinib Demonstrates Clinically Meaningful Intracranial Antitumor Activity in Patients with NSCLC with EGFR Exon 20 Insertion or Uncommon EGFR Mutations and Active CNS Metastases
Oct 19, 2026
Closed $13.98 (+8.1%) on Oct 19, 2026
Cullinan Therapeutics Announces First Patient Dosed in Planned Registrational Phase 2 Study of CLN-049 in Relapsed/Refractory Acute Myeloid Leukemia
Oct 8, 2026
Closed $15.46 (-1.1%) on Oct 8, 2026
New Drug Application Submission Initiated for Zipalertinib Plus Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation NSCLC for Review Under FDA Real-Time Oncology Review Program
Oct 1, 2026
Closed $15.51 (+6.7%) on Oct 2, 2026
Cullinan Therapeutics Highlights Fourth Quarter 2026 Milestones Across Immunology and Oncology T Cell Engager Portfolio
Sep 24, 2026
Closed $15.44 (-8.5%) on Sep 24, 2026
Cullinan Therapeutics to Participate in the Stifel 2026 Virtual Immunology and Inflammation Forum
Sep 21, 2026
Closed $21.35 (+1.3%) on Sep 21, 2026
Cullinan Therapeutics to Host Virtual Analyst and Investor Event Today to Feature Zipalertinib Plus Chemotherapy Phase 3 REZILIENT3 Data Presented at the IASLC 2026 World Conference on Lung Cancer
Sep 14, 2026
Closed $20.40 (-0.9%) on Sep 14, 2026
Zipalertinib Plus Chemotherapy Demonstrates 6-Month Median Progression-Free Survival Benefit in REZILIENT3 Phase 3 Trial in First-Line EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer
Sep 13, 2026
Closed $20.40 (-0.9%) on Sep 14, 2026
Cullinan Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results
Aug 6, 2026
Closed $17.95 (+1.9%) on Aug 6, 2026
Decks
Investor Presentation (October 2026)
Investor deck · 64 slides · October 2026
WCLC 2026
Conference · 15 slides · September 2026
Investor Presentation (September 2025)
Investor deck · 53 slides · Sep 4, 2025
Technical Presentation (September 2025)
Technical · 17 slides · September 2025
Cullinan Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 29 in the last 12 months · 125 in all · newest Oct 27, 2026 · oldest 2021
- Decks
- 16 decks · latest October 2026
Where Cullinan Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CGEM · Home listing | NASDAQ | United States | USD |
| BOATS:CGEM · This page | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Cullinan Therapeutics, Inc.